Chetan N. Shenoy

Chetan Shenoy practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Chetan Shenoy's NPI, 1346571320, was assigned on January 14, 2010. Chetan Shenoy holds Minnesota license 261QM1300X.

Chetan Shenoy's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Chetan Shenoy's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Chetan Shenoy to 10 more medical groups, 6 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Chetan Shenoy practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Chetan Shenoy's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Chetan Shenoy's licenses on file in 2 states: Minnesota and North Carolina.

CMS data shows 22 Medicare services from Chetan Shenoy across 1 procedure code in 2024, for 56 Medicare patients. Medicare paid $1,921 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Chetan Shenoy in 2024. The largest group is 65 to 74, with 25 patients. 70% of them have high blood pressure, and 59% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Chetan Shenoy's median patient age at 58, with 49% women.

In 2024, Chetan Shenoy wrote 161 Medicare Part D claims for 32 patients. 74% of them were for generic drugs. CMS names the drug for 90 of them, across 6 drugs with 11 or more claims each, at $25,082 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Chetan Shenoy for performance year 2024, reported as part of a group. Chetan Shenoy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 92 papers to Chetan Shenoy, published from 2010 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Magnetic Resonance Imaging, Magnetic Resonance Imaging, Cine and Predictive Value of Tests. Chetan Shenoy has published most often in Eur Heart J Cardiovasc Imaging. Chetan Shenoy's most frequent co-authors are Dipan Shah, MD, John F. Heitner, MD and Prabhjot S. Nijjar, MD.

Dmand AI links Chetan Shenoy to 1 clinical trial. Conditions studied include Cardiotoxicity and Drug-Related Side Effects and Adverse Reactions.

CMS Open Payments shows 3 general payments to Chetan Shenoy from 3 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 81% of the total. Medtronic, Inc. paid the most, $530.